New Covenant Trust Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
HCM
FWCM
MSV
AIM
EB
SC
AP
IWA
MPWT
FFA
New Covenant Trust Company's ABBV Position: Q3 2026 in Review
New Covenant Trust Company increased its AbbVie (ABBV) stake by 14% in Q3 2026, buying an estimated $83.1K and bringing the position to 2,600 shares worth $680K. The position accounts for 0.47% of the portfolio, ranked #36.
New Covenant Trust Company first reported a position in ABBV in Q1 2024 and has held it in 11 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- New Covenant Trust Company held 2,600 shares of AbbVie worth $680K as of Q3 2026.
- New Covenant Trust Company bought 324 AbbVie shares in Q3 2026, an estimated $83.1K.
- AbbVie made up 0.47% of New Covenant Trust Company's portfolio in Q3 2026, its #36 holding.
- New Covenant Trust Company first reported a position in AbbVie in Q1 2024 and has held it in 11 quarters since.
- 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on New Covenant Trust Company's 13F filing for Q3 2026, filed 8 Oct 2026.